diabetes

May 23, 2023

Diabetes Day celebrates 50 years of achievement, spotlights current investigations

Vanderbilt Diabetes Day, an annual event hosted by the now-named Vanderbilt Diabetes Research and Training Center (DRTC). The event spotlights the work of researchers, and this year also celebrated the 50-year anniversary of the DRTC.

By Jill Clendening
May 19, 2023

Gorden honored with Vanderbilt Diabetes Center Lifetime Achievement Award

Phillip Gorden, MD, a Vanderbilt University undergraduate and School of Medicine alumnus, was recently honored with the Vanderbilt Diabetes Center Lifetime Achievement Award, during the recent Diabetes Day sponsored by the Vanderbilt Diabetes Research and Training Center and the Irwin B. Eskind Endowed Symposium.

By Jill Clendening
May 8, 2023

Diabetes drugs associated with fewer adverse cardiac events in older veterans: study

Vanderbilt research finds that GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

By Leigh MacMillan
April 24, 2023

Kenneth Reynolds weighed 780 lbs., and his body was shutting down. Vanderbilt Weight Loss Center gave him back his life.

Coming up: going fishing with his grandchildren

By Jill Clendening
Creators of the diabetes toolkit included, from left, Charis Health Center’s Carolyn Moore and Lauren Smith and VUMC’s Lindsay Miller, Lucy Leon, Bianca Sarr, Hannah Beddoe, Autumn Montgomery and Kimberly Burkeen.
April 6, 2023

Nurses collaborate to create Diabetes Education Toolkit

Vanderbilt recently collaborated with Charis Health Center in Wilson County to create a Diabetes Education Toolkit to better serve Charis’ patient population.

By Matt Batcheldor
March 23, 2023

Study sheds light on drug’s impact on diabetes progression

A Vanderbilt study of a treatment to delay the development of Type 1 diabetes in individuals at high risk did not meet the study goals of delaying progression from normal glucose tolerance to abnormal glucose tolerance or clinical diagnosis, although the study drug, abatacept, impacted immune response and preserved insulin production during the one-year treatment period.

By Craig Boerner
March 23, 2023

Saunders receives diabetes research innovation award

Vanderbilt's Diane Saunders, PhD, has been selected as a 2023 recipient of an Innovation Award by the Network of Pancreatic Donors with Diabetes.
By Jill Clendening
March 15, 2023

Ashcroft named to receive Vanderbilt Prize in Biomedical Science

Professor Dame Frances Ashcroft, a British physiologist known internationally for her work on insulin secretion, Type 2 diabetes and neonatal diabetes, is the recipient of the 2023 Vanderbilt Prize in Biomedical Science.
By Bill Snyder
March 9, 2023

Family’s participation key to advancing diabetes research

A study of one family from Alabama has led Vanderbilt researchers to discover that insulin deficiency, independent of the autoimmunity associated with Type 1 diabetes, is the principal factor leading to a markedly smaller pancreas.
By Jill Clendening
February 21, 2023

Diabetes drug may improve asthma

New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.
By Sarah E. Glass
January 12, 2023

Study may lead to new diabetes, heart disease treatments

Vanderbilt research found that deletion of an autophagy-participating factor named PIK3C3 from the fat cells of mice led to compromised body temperature control, abnormal blood lipid levels, fatty liver and diabetes.
By Bill Snyder
October 24, 2022

Metabolic signatures of Type 2 diabetes risk

Vanderbilt epidemiologists found 32 blood metabolites associated with obesity and showed that adding these to traditional disease prediction models improves accuracy of determining Type 2 diabetes risk.
By Kelsey Pinckard
October 20, 2022

Aging beta cells hasten Type 2 diabetes

Vanderbilt investigators have found that aging induces chronic cellular stress in pancreatic beta cells, which could contribute to the development of diabetes as we age.
By Bill Snyder
1 2 3 4 5 … 18